Collection of Blood From Therapeutic Trial Participants for Analysis of Genetic Differences in Drug Disposition and Pharmacokinetics of Probe Medications
Condition: Prostate Cancer, Breast Cancer, Lung Cancer, Ovarian Cancer, Lymphoma
Study Type: Observational
Clinical Trials Identifier NCT 8-digits: NCT01441089
Sponsor: National Cancer Institute (NCI)
Phase:
Eligibility:
- Age: minimum 3 Years maximum N/A
- Gender: All
Inclusion Criteria:
- Any individual currently enrolled in an NIH intramural research program clinical trials receiving treatment.
- Ability of participant or Legally Authorized Representative (LAR) to understand and be willing to sign the informed consent document.
- Age >= 3 years old
Exclusion Criteria:
- -N/A
View trial on ClinicalTrials.gov